Ultragenyx Pharmaceutical (RARE) Receivables - Other (2017 - 2026)
Ultragenyx Pharmaceutical (RARE) recorded Receivables - Other of $1 million in Q2 2026, up 11.1% from $900,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Ultragenyx Pharmaceutical (RARE) Receivables - Other (2017 - 2026) Analysis & Trends
Starting with Q4 2017, Ultragenyx Pharmaceutical's Receivables - Other history includes 32 quarters.
- Annual Receivables - Other has a five-year compound annual growth rate of -36.4% (FY2020 to FY2025).
- Across earlier years, Receivables - Other came in at $2 million in FY2024 (+81.8%), $1.1 million in FY2023 (-82.8%), $6.4 million in FY2022 (-60.0%) and $16 million in FY2021 (+66.7%).
- Quarterly Receivables - Other has ranged from $200,000 in Q1 2024 to $16 million in Q4 2021 over the past five years.
- On a year-over-year basis, Receivables - Other rose in four of the last seven quarters, with growth averaging 41.3%.
- Peak year-over-year performance for Receivables - Other in the last five years was growth of 350.0% in Q3 2024, against a decline of 98.4% in Q1 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $1 million (Q1 2026), $1 million (Q4 2025) and $2.1 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Ultragenyx Pharmaceutical | 1.48 Bn | -321.29 Mn | 180.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.00 Mn |
| Mar 31, 2026 | 1.00 Mn |
| Dec 31, 2025 | 1.00 Mn |
| Sep 30, 2025 | 2.10 Mn |
| Jun 30, 2025 | 900,000.00 |
| Mar 31, 2025 | 2.40 Mn |
| Dec 31, 2024 | 2.00 Mn |
| Sep 30, 2024 | 1.80 Mn |
| Jun 30, 2024 | 2.40 Mn |
| Mar 31, 2024 | 200,000.00 |
| Dec 31, 2023 | 1.10 Mn |
| Sep 30, 2023 | 400,000.00 |
| Jun 30, 2023 | 2.30 Mn |
| Mar 31, 2023 | 12.70 Mn |
| Dec 31, 2022 | 6.40 Mn |
| Sep 30, 2022 | 3.20 Mn |
| Jun 30, 2022 | 2.90 Mn |
| Mar 31, 2022 | 3.80 Mn |
| Dec 31, 2021 | 16.00 Mn |
| Sep 30, 2021 | 3.70 Mn |
API Access
Ultragenyx Pharmaceutical Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=RARE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "RARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=RARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();